Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.
Stacey OrangiJohn OjalSamuel Pc BrandCameline OrlendoAngela KairuRabia AzizaMorris OgeroAmbrose AgweyuGeorge M WarimweSophie UyogaEdward OtienoLynette I Ochola-OyierCharles N AgotiKadondi KaseraPatrick AmothMercy MwangangiRashid AmanWangari Ng'ang'aIfedayo Mo AdetifaJ Anthony G ScottPhilip BejonMatt J KeelingStefan FlascheD James NokesEdwine W BarasaPublished in: BMJ global health (2022)
With prior exposure partially protecting much of the Kenyan population, vaccination of young adults may no longer be cost-effective.
Keyphrases